Sun Pharma presents data from Phase 1 studies of GL0034
GL0034 is a novel, investigational glucagon-like peptide 1 receptor agonist (GLP-1RA) being studied for the treatment of type 2 diabetes and obesity
GL0034 is a novel, investigational glucagon-like peptide 1 receptor agonist (GLP-1RA) being studied for the treatment of type 2 diabetes and obesity
This partnership will revolutionize Pharmarack's digital infrastructure with Snowflake's single, integrated platform to facilitate advanced analytic
The start-up.ai team will be integrated into Verix, boosting its innovative Life Science AI capabilities
Convergent action on AMR identified as an important area of intervention
Lantern is receiving an exclusive and worldwide option to license intellectual property from Bielefeld University related to the collaboration and IP generated from the collaboration
The development and deployment of effective vaccines can help to mitigate the impact of pandemics, and we must prioritize research efforts to achieve this objective
The oCelloscope technology is a unique live-cell imaging system for sensitive and detailed monitoring of biological growth and development
Acquisition enhances Freenome's product portfolio, including autoantibody platform with additional biomarkers important in cancer detection
Subscribe To Our Newsletter & Stay Updated